chr8-33503741-G-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001102401.4(TTI2):c.1115+7C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000304 in 1,613,148 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001102401.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTI2 | NM_001102401.4 | c.1115+7C>G | splice_region_variant, intron_variant | ENST00000431156.7 | NP_001095871.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTI2 | ENST00000431156.7 | c.1115+7C>G | splice_region_variant, intron_variant | 1 | NM_001102401.4 | ENSP00000411169 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00169 AC: 257AN: 152134Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000325 AC: 81AN: 249058Hom.: 2 AF XY: 0.000245 AC XY: 33AN XY: 134746
GnomAD4 exome AF: 0.000159 AC: 233AN: 1460896Hom.: 1 Cov.: 32 AF XY: 0.000150 AC XY: 109AN XY: 726738
GnomAD4 genome AF: 0.00169 AC: 257AN: 152252Hom.: 2 Cov.: 32 AF XY: 0.00165 AC XY: 123AN XY: 74434
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | TTI2: BP4, BS2 - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 03, 2017 | - - |
TTI2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 22, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at